← Open Payments lookup

PETER CHUNG: Open Payments

NPI 1720083694 · SANTA CLARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,118 in 47 payments from 11 companies in 2025. Trend: 2023 $2,256 · 2024 $1,417 · 2025 $1,118

Food & beverage: $1,118
CompanyPaymentsAmount
Novo Nordisk Inc20$452
AstraZeneca Pharmaceuticals LP8$212
GlaxoSmithKline, LLC.5$124
Boehringer Ingelheim Pharmaceuticals, Inc.3$80
IBSA Pharma Inc.3$64
Lilly USA, LLC3$58
SANOFI-AVENTIS U.S. LLC1$34
ABBVIE INC.1$28
Amgen Inc.1$26
Bayer Healthcare Pharmaceuticals Inc.1$25

Products named: Ozempic, FARXIGA, Rybelsus, AREXVY, JARDIANCE, Tirosint, MOUNJARO, Wegovy.

Industry payments across CA — which companies pay providers there.